TrialFrontiers in immunology2026

Safety, immunogenicity, and long COVID outcomes following inactivated COVID-19 vaccine boosters in elderly Chinese: a prospective cohort study.

Rongrong Dai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.